This cohort study uses data from the Transcatheter Valve Therapy Registry to examine health outcomes among patients undergoing transcatheter mitral valve repair for mitral regurgitation.
This secondary analysis of a randomized clinical trial assesses if different biomarkers provide information about the risk for all-cause and cause-specific mortality after acute coronary syndrome.
This cohort study determines whether proportion of genetically determined African ancestry is associated with increased electrocardiographic voltage and concentric LV hypertrophy in black compared with white individuals.
This cohort study uses data from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II to assess racial/ethnic differences in the use of oral anticoagulants by patients with atrial fibrillation.
This autopsy study tests whether epigenetic signatures characterize early fetal atherogenesis associated with maternal hypercholesterolemia and provides a quantitative estimate of the contribution of maternal cholesterol level to fetal lesion size.
This randomized survey study explores how communication tools and presentation formats influence the perception of the severity of atherosclerotic cardiovascular disease risk as well as the potential willingness to take medication therapy among patients in the Patient and Provider Assessment of Lipid Management Registry.
This study examines the incidence of atrial fibrillation in a cohort of elite athletes.
This case-control study investigates whether if the normalized reciprocal of the plasma level of cardiac bridging integrator 1 protein differs in patients with heart failure with preserved ejection fraction, patients with risk factors for heart failure, and individuals with neither heart failure nor risk factors.
This secondary analysis of the ASTRONOMER randomized clinical trial assesses whether plasma levels of lipoprotein(a) have a linear or a threshold association with rate of progression among patients with calcific aorta valve stenosis.
This study investigates the correlation of online symptom search for chest pain using Google Trends with disease prevalence of coronary heart disease.
This cross-sectional study examines 30-day risk-standardized mortality rates for coronary artery bypass grafting, acute myocardial infarction, and heart failure at top-ranked US News & World Report cardiology vs nonranked hospitals.
This study calculates estimated 5-year number needed to treat values for the primary outcome of cardiovascular death or heart failure hospitalization with angiotensin receptor-neprilysin inhibitor therapy incremental to angiotensin-converting enzyme inhibitor in patients with heart failure with reduced ejection fraction (HFrEF) in the PARADIGM-HF trial.
This study examines cohorts of Yanomami and Yekwana individuals in Venezuela to assess how age affects blood pressure rise over time in isolated communities without Western exposure.
This study uses Altmetric scores to identify and describe the articles in 4 major cardiovascular journals that garnered the most digital attention in 2017.
This Viewpoint describes reasons why the Centers for Medicare and Medicaid Services should revisit a coverage decision affecting the ability of patients with pacemakers or implantable cardioverter-defibrillators to access magnetic resonance imaging.
This essay describes the author’s experience with Wolff-Parkinson-White syndrome and how it has translated to her medical career.
This narrative review examines whether angiotensin II receptor blockade coupled with potentiation of key biological signaling pathways can favorably alter the course of heart failure with reduced ejection fraction.
A 62-year-old woman unsuccessfully resuscitated after a cardiac arrest had elevated cardiac enzyme levels, ST-segment depression on the precordial leads, and wall motion abnormalities on TTE involving the midventricular wall without involvement of the basal of apical segments of the left ventricle. What would you do next?